A synthetic derivative of houttuynoid B prevents cell entry of Zika virus.
A synthetic derivative of houttuynoid B prevents cell entry of Zika virus.
Antiviral Res. 2019 Nov 04;:104644
Authors: Basic M, Elgner F, Bender D, Sabino C, Herrlein ML, Roth H, Glitscher M, Fath A, Kerl T, Schmalz HG, Hildt E
Abstract
Zika virus (ZIKV) is a re-emerging virus belonging to the family of Flaviviridae, which contains several human pathogens. A great deal of attention came through the association of ZIKV infection with an increasing number of microcephaly cases in newborns during the 2016 outbreak in Brazil. Currently, no anti-viral drug or vaccine is available. Houttuynoids are a group of structurally related flavonoid glycosides that can be isolated from Houttuynia cordata belonging to the family of Sauraceae. Moreover, H. cordata was described to have an antiviral effect on herpes simplex virus type 1 (HSV-1), human immunodeficiency virus type 1 (HIV-1) and influenza A virus (Hayashi et al., 1995). In light of this, this study aimed to investigate a potential antiviral effect of the synthetic houttuynoids TK1023 and TK1024 (i.e. houttuynoid B) on two ZIKV isolates (Uganda and French Polynesia). A significant decrease in the amount of intra- and extracellular viral genomes as well as infectious viral particles was observed after treatment with the tetra-O-acetylated houttuynoid TK1023 independent from the analyzed virus isolate. In contrast, TK1024 (houttuynoid B) had no effect on ZIKV. Treatment with TK1023 significa...
Source: Antiviral Research - Category: Virology Authors: Basic M, Elgner F, Bender D, Sabino C, Herrlein ML, Roth H, Glitscher M, Fath A, Kerl T, Schmalz HG, Hildt E Tags: Antiviral Res Source Type: research
More News: Brazil Health | Cold Sores | Flavonoids | France Health | Herpes | Influenza | Influenza Vaccine | Outbreaks | Science | Study | Uganda Health | Vaccines | Virology | Zika Virus